Phase 2
18 Years
N/A
Not Enrolling
Both
Carcinoma, Renal Cell, Kidney Neoplasms

Thank you

Trial Information


Inclusion Criteria:



- Newly diagnosed metastatic renal cell carcinoma

- Suitable for nephrectomy

Exclusion Criteria:

- Prior chemotherapy, biological therapy or radiation therapy for renal cell carcinoma
or within the last 3 years for any other cancer

- Significant cardiac event within 3 months of entry

- Any history of coronary angioplasty or history of myocardial infarction

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

D2820C00018

NCT ID:

NCT00065572

Start Date:

August 2003

Completion Date:

February 2004

Related Keywords:

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Kidney Cancer
  • Metastatic
  • Newly diagnosed renal cell carcinoma
  • Neoplasms
  • Carcinoma
  • Carcinoma, Renal Cell
  • Kidney Neoplasms

Name

Location
Research Site Anaheim, California  
Research Site Lewes, Delaware  
Research Site Boca Raton, Florida  
Research Site Arlington Heights, Illinois  
Research Site Bloomington, Indiana  
Research Site Baltimore, Maryland  
Research Site Branson, Missouri  
Research Site Hooksett, New Hampshire  
Research Site Belleville, New Jersey  
Research Site Albany, New York  
Research Site Akron, Ohio  
Research Site Bend, Oregon  
Research Site Allentown, Pennsylvania  
Research Site Chattanooga, Tennessee  
Research Site Ivins, Utah